Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Run-Lin Gao

Showing results (251-260 of 308) with videos related to

Pageof 31
Sort By:
Chinese Medical Journal|April 20, 2006
A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patientsBo Xu, Jian-jun Li, Yue-jin Yang, et al.
Chinese Medical Journal|May 26, 2010
Comparison of long-term clinical outcome after successful implantation of Firebird sirolimus- and Taxus paclitaxel-eluting stents in Chinese population: analysis of a large single center registryKe-Fei Dou, Bo Xu, Yue-Jin Yang, et al.
Clinical Cardiology|May 30, 2009
Long-term clinical efficacy of cutting balloon angioplasty followed by bare metal stent implantation for treating ostial left anterior descending artery lesionsLi-Jian Gao, Ji-Lin Chen, Jun Chen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 11, 2023
First-in-human evaluation of a novel ultrathin sirolimus-eluting iron bioresorbable scaffold: 3-year outcomes of the IBS-FIM trialRun-Lin Gao, Bo Xu, Zhongwei Sun, et al.
Chinese Medical Journal|May 6, 2011
Comparison of long-term clinical outcome after successful implantation of FIREBIRD and CYPHER sirolimus-eluting stents in daily clinical practice: analysis of a large single-center registryBo Xu, Ke-Fei Dou, Yue-Jin Yang, et al.
Frontiers in Endocrinology|June 6, 2022
Hyperuricemia is Associated With 2- and 5-Year Adverse Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary InterventionXiao-Fang Tang, Chen He, Pei Zhu, et al.
Coronary Artery Disease|December 10, 2009
Treatment of mild-moderate calcified coronary lesions with sirolimus-eluting stent: real world data from a single centerJin-Qing Yuan, Jian-Jun Li, Xue-Wen Qin, et al.
Bioactive Materials|May 24, 2024
Long-term efficacy, safety and biocompatibility of a novel sirolimus eluting iron bioresorbable scaffold in a porcine modelYa-Nan Gao, Hong-Tao Yang, Zi-Feng Qiu, et al.
Chinese Medical Journal|October 3, 2020
Clinical characteristics of early and late drug-eluting stent in-stent restenosis and mid-term prognosis after repeated percutaneous coronary interventionJian-Feng Zheng, Ting-Ting Guo, Yuan Tian, et al.
Chinese Medical Journal|January 23, 2008
Effects of sirolimus-eluting stent on calcified coronary lesionsJian-jun Li, Bo Xu, Yue-jin Yang, et al.
Pageof 31

Showing results (251-260 of 308) with videos related to

Sort By:
Pageof 31
Chinese Medical Journal|April 20, 2006
A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patientsBo Xu, Jian-jun Li, Yue-jin Yang, et al.
Chinese Medical Journal|May 26, 2010
Comparison of long-term clinical outcome after successful implantation of Firebird sirolimus- and Taxus paclitaxel-eluting stents in Chinese population: analysis of a large single center registryKe-Fei Dou, Bo Xu, Yue-Jin Yang, et al.
Clinical Cardiology|May 30, 2009
Long-term clinical efficacy of cutting balloon angioplasty followed by bare metal stent implantation for treating ostial left anterior descending artery lesionsLi-Jian Gao, Ji-Lin Chen, Jun Chen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 11, 2023
First-in-human evaluation of a novel ultrathin sirolimus-eluting iron bioresorbable scaffold: 3-year outcomes of the IBS-FIM trialRun-Lin Gao, Bo Xu, Zhongwei Sun, et al.
Chinese Medical Journal|May 6, 2011
Comparison of long-term clinical outcome after successful implantation of FIREBIRD and CYPHER sirolimus-eluting stents in daily clinical practice: analysis of a large single-center registryBo Xu, Ke-Fei Dou, Yue-Jin Yang, et al.
Frontiers in Endocrinology|June 6, 2022
Hyperuricemia is Associated With 2- and 5-Year Adverse Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary InterventionXiao-Fang Tang, Chen He, Pei Zhu, et al.
Coronary Artery Disease|December 10, 2009
Treatment of mild-moderate calcified coronary lesions with sirolimus-eluting stent: real world data from a single centerJin-Qing Yuan, Jian-Jun Li, Xue-Wen Qin, et al.
Bioactive Materials|May 24, 2024
Long-term efficacy, safety and biocompatibility of a novel sirolimus eluting iron bioresorbable scaffold in a porcine modelYa-Nan Gao, Hong-Tao Yang, Zi-Feng Qiu, et al.
Chinese Medical Journal|October 3, 2020
Clinical characteristics of early and late drug-eluting stent in-stent restenosis and mid-term prognosis after repeated percutaneous coronary interventionJian-Feng Zheng, Ting-Ting Guo, Yuan Tian, et al.
Chinese Medical Journal|January 23, 2008
Effects of sirolimus-eluting stent on calcified coronary lesionsJian-jun Li, Bo Xu, Yue-jin Yang, et al.
Pageof 31